Case Study: Global Biopharmaceutical Company reduces clinical trial risk by improving site monitor proficiency for Risk-Based Monitoring with Qstream

Global Biopharmaceutical Leader Reduces Clinical Trial Risks by Improving Site Monitor Proficiency for Risk Based Monitoring (RBM)

A global biopharmaceutical leader faced rising clinical trial risks due to inconsistent site monitor proficiency for Risk-Based Monitoring (RBM). With evolving regulations and SOPs making classroom training costly and slow, the company needed a faster way to identify competency gaps and reduce costly trial delays that threaten patient safety and timelines.

They implemented Qstream’s challenge-based microlearning—scenario-driven questions that provide real-time proficiency data, gap assessments, and continuous reinforcement. The approach enabled targeted coaching, improved critical thinking and on-the-job behaviors, increased compliance with ICH/GCP/SOPs, and delivered measurable ROI from the pilot within the first year.